Abstract
Ipratropium bromide is a bronchodilator whose effect has been compared with beta agonists but not with theophylline. Twelve asthmatics were given four two-week courses of the different combinations of ipratropium (40 micrograms in two puffs), theophylline capsules, and their corresponding placebos in a random, double-blind fashion. There was a significant increase in FEV1 and MMFR 60 minutes after theophylline was administered (p less than 0.05) when measured after one and two weeks of therapy. FEV1 and MMFR were significantly increased (p less than 0.05) 30 and 60 minutes after ipratropium inhalation and this increase was significantly greater when the patient had also been taking theophylline compared with placebo capsules (p less than 0.05). There was no toxicity associated with this combination. The synergism demonstrated may be related to the time sequence of drug administration, mechanical or cellular factors.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Austen K. F., Orange R. P. Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis. 1975 Sep;112(3):423–436. doi: 10.1164/arrd.1975.112.3.423. [DOI] [PubMed] [Google Scholar]
- Cavanaugh M. J., Cooper D. M. Inhaled atropine sulfate: dose response characteristics. Am Rev Respir Dis. 1976 Sep;114(3):517–524. doi: 10.1164/arrd.1976.114.3.517. [DOI] [PubMed] [Google Scholar]
- Emirgil C., Dwyer K., Baskette P., Sobol B. J. A new parasympatholytic bronchodilator: a study of its onset of effect after inhalation. Curr Ther Res Clin Exp. 1975 Mar;17(3):215–224. [PubMed] [Google Scholar]
- Gross M. J. Sch 1000: a new anticholinergic bronchodilator. Am Rev Respir Dis. 1975 Dec;112(6):823–828. doi: 10.1164/arrd.1975.112.6.823. [DOI] [PubMed] [Google Scholar]
- Minette A., Marcq M., Bruninx M., Spaas B., Van Hove G. Résultats d'une recherche sur les effets ventilatoires et associés du Sch 1000 en aérosol chez 54 patients atteints de bronchoobstruction réversible. Rev Inst Hyg Mines (Hasselt) 1973;28(1):22–38. [PubMed] [Google Scholar]
- Petrie G. R., Palmer K. N. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma. Br Med J. 1975 Feb 22;1(5955):430–432. doi: 10.1136/bmj.1.5955.430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poppius H., Salorinne Y. Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis. Br Med J. 1973 Oct 20;4(5885):134–136. doi: 10.1136/bmj.4.5885.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Storms W. W., DoPico G. A., Reed C. E. Aerosol Sch 1000. An anticholinergic bronchodilator. Am Rev Respir Dis. 1975 Apr;111(4):419–422. doi: 10.1164/arrd.1975.111.4.419. [DOI] [PubMed] [Google Scholar]
- Yeager H., Jr, Weinberg R. M., Kaufman L. V., Katz S. Asthma: comparative bronchodilator effects of ipratropium bromide and isoproterenol. J Clin Pharmacol. 1976 Apr;16(4):198–204. doi: 10.1002/j.1552-4604.1976.tb01518.x. [DOI] [PubMed] [Google Scholar]